Tretinoin

Tretinoin

SCHEMBL3145

CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

RARARARBRARG

The experimentally established mechanism targets of Tretinoin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA known ✓ P10276 4/20 1.00
RARB known ✓ P10826 4/20 1.00
RARG known ✓ P13631 4/20 1.00
ALDH1A1 P00352 12/20 1.00
MAPT P10636 9/20 1.00
CYP3A4 P08684 6/20 1.00
RXRA P19793 5/20 1.00
PTGS1 P23219 4/20 1.00
APP P05067 4/20 1.00
SNCA P37840 4/20 1.00
MAPK1 P28482 3/20 1.00
ALOX15 P16050 3/20 1.00
RXRB P28702 2/20 1.00
RXRG P48443 2/20 1.00
RORC P51449 2/20 1.00
ADORA3 P0DMS8 2/20 1.00
HTR2B P41595 2/20 1.00
BLM P54132 2/20 1.00
HIF1A Q16665 2/20 1.00
DRD3 P35462 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tretinoin SCHEMBL3146 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Isotretinoin SCHEMBL9123793 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Tretinoin SCHEMBL8399912 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Tretinoin SCHEMBL7846921 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Tretinoin SCHEMBL24982760 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Isotretinoin SCHEMBL38299 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Tretinoin SCHEMBL24982761 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Alitretinoin SCHEMBL5331051 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Tretinoin SCHEMBL18667 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA
Isotretinoin SCHEMBL20603086 1.00 ALDH1A1 (1.00) ALDH1A1MAPTCYP3A4RXRARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 217994 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
EP-4748859-A2 CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF The Regents of the University of California (US) 2026-05-27 EP claimed
EP-4746852-A1 LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION Universität Bern (CH) 2026-05-27 EP claimed
EP-3594323-B1 METHODS AND COMPOSITIONS FOR GENERATING PANCREATIC PROGENITORS AND FUNCTIONAL BETA CELLS FROM HPSCS UNIV HEALTH NETWORK (CA) 2026-05-27 EP claimed
CN-119874824-B IL17RA targeting polypeptides and lysosome targeting chimeras and their use in the treatment of psoriasis Innovation Research Institute of Hebei University of Technology (Shijiazhuang) (CN) 2026-05-26 CN claimed
CN-118873499-B Preparation and application of multifunctional nano preparation for activating tumor in-situ vaccine to generate immune response CHINA PHARMACEUTICAL UNIVERSITY (CN) 2026-05-26 CN claimed
CN-116850183-B Methods and pharmaceutical compositions for treating myopia GRAND PHARMA (CHINA) Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-122080237-A Preparation method of ovarian stem cells and application of ovarian stem cells in preparation of ovarian anti-aging drugs 2026-05-26 CN claimed
CN-122075435-A Brain-targeted neutral granulocyte membrane-encapsulated tanshinone IIa PLGA nano preparation and preparation method and application thereof 2026-05-26 CN claimed
CN-122095095-A Ribonucleic acid construct capable of inducing immune response, pharmaceutical composition and kit comprising same 2026-05-26 CN claimed
US-4201778-A 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates SCHERING CORPORATION (US) 1980-05-06 US claimed
US-4190594-A ABSORBERS OF ULTRAVIOLET RADIATION JOHNSON & JOHNSON (US) 1980-02-26 US claimed
US-4189501-A BENZOYL PEROXIDE, GLYCEROL A. H. C. Pharmacal, Inc. (US) 1980-02-19 US claimed
US-4185099-A ANTIDANDRUFF AGENTS Also Laboratori S.a.S. di Dr.P. Sorbini & C (IT) 1980-01-22 US claimed
EP-0003064-A2 Method for introducing analogs of vitamin A into the respiratory tract of a cigarette smoker Rabam Limited (BM) 1979-07-25 EP claimed
EP-0001864-A1 Novel 6-oxygenated-3,20-dioxo-pregnane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them Technobiotic Ltd. (CH) 1979-05-16 EP claimed
US-4124707-A 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor SCHERING CORPORATION (US) 1978-11-07 US claimed
US-4108880-A ULTRAVIOLET ABSORBERS JOHNSON & JOHNSON (US) 1978-08-22 US claimed
US-4073291-A Topical device for administering tretinoin JOHNSON & JOHNSON (US) 1978-02-14 US claimed
US-3984544-A Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor SCHERING CORPORATION (US) 1976-10-05 US claimed